Brian Dawson

Senior Director, Process Development at HbO2 Therapeutics

Mr. Dawson has over 25 years of experience in the development and commercialization of Hemopure and Oxyglobin, and is leading the efforts to consolidate three manufacturing sites down to a single facility in Souderton, PA. He has held multiple positions in manufacturing operations and has an extensive skillset in all facets of production, maintenance, calibration, supply chain, process engineering, validation, environmental control, and aseptic fill finish. Brian was Director of Operations for both Biopure and OPK Biotech LLC, and has a BA from North Adams State College (Massachusetts College of Liberal Arts).


Org chart

No direct reports

Teams


Offices

This person is not in any offices


HbO2 Therapeutics

1 followers

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body.


Industries

Employees

11-50

Links